Cerulean Pharma (CERU) Tops Q3 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. FIX
9. TSCO
10. BE

Go back to Cerulean Pharma (CERU) Tops Q3 EPS by 2c

Wedbush Reiterated an Outperform on Cerulean Pharma (CERU) Following 3Q

November 17, 2015 1:18 PM EST

Wedbush reiterated an Outperform rating on Cerulean Pharma (NASDAQ: CERU), and cut the price target to $9.00 (from $16.00), following the company's 3Q earnings report. CERU reported a net loss of $10.6M ($0.39/share), slightly above consensus of ($0.41).

Analyst David Nierengarten commented, "CERU reported a net... More